Literature DB >> 33708292

Prevalence and pattern of dyslipidemia in patients with type 2 diabetes mellitus in Zaria, Northwestern Nigeria.

Beatrice Ohunene Bello-Ovosi1, Joseph Ogirima Ovosi2, Modupe Arinola Ogunsina1, Sunday Asuke3, Muhammed Sani Ibrahim4.   

Abstract

INTRODUCTION: Dyslipidemia confers excess atherosclerotic cardiovascular risk in type 2 diabetes mellitus (DM) patients, and this requires prompt identification and management to reduce morbidity and mortality. This study assessed the prevalence and pattern of dyslipidemia in type 2 DM patients in Zaria, Northwestern Nigeria.
METHODS: This was a cross-sectional study of newly diagnosed type 2 DM patients at Ahmadu Bello University Teaching Hospital (ABUTH), Zaria. Demographic, clinical and laboratory data were extracted from the case notes of eligible patients and analyzed using STATA version 14. Continuous variables were presented as mean ± standard deviation (SD), or median and interquartile range (IQR) while categorical variables were as frequencies and percentages. Student t and chi-square tests were used to test for association at p < 0.05.
RESULTS: A total of 322 subjects (161 male, 161 female) with a mean age of 53.5 ± 10.8 years partook in the study. The prevalence of dyslipidemia was 69.3%. Mixed dyslipidemia of high triglyceride (TG) and high low-density lipoprotein cholesterol (LDL-C) was present in 41.0%; high TG and low high-density lipoprotein cholesterol (HDL-C) in 2.8%; and high LDL and low HDL in 2.5%. Atherogenic dyslipidemia, isolated hypercholesterolemia and isolated low HDL-cholesterol were present in 3.4%, 2.5% and 23.6% respectively. Dyslipidemia status was not associated with age, sex, duration of DM or hypertension, obesity, and mean fasting blood sugar (FBS) and 2-hour postprandial glucose.
CONCLUSION: The prevalence of dyslipidemia is high in the newly diagnosed type 2 DM patients and therefore, initial management should incorporate measures to control dyslipidemia. © Beatrice Ohunene Bello-Ovosi et al.

Entities:  

Keywords:  Nigeria; Prevalence; diabetes mellitus; dyslipidemia

Mesh:

Substances:

Year:  2019        PMID: 33708292      PMCID: PMC7906549          DOI: 10.11604/pamj.2019.34.123.18717

Source DB:  PubMed          Journal:  Pan Afr Med J


  35 in total

1.  Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients.

Authors:  Handrean Soran; Michael W France; See Kwok; Sanjaya Dissanayake; Valentine Charlton-Menys; Nahla N Younis; Paul N Durrington
Journal:  Ann Clin Biochem       Date:  2011-10-17       Impact factor: 2.057

2.  Dyslipidemias in type 2 diabetes mellitus patients in Nnewi South-East Nigeria.

Authors:  N N Jisieike-Onuigbo; E I Unuigbe; C O Oguejiofor
Journal:  Ann Afr Med       Date:  2011 Oct-Dec

3.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Authors:  C Baigent; A Keech; P M Kearney; L Blackwell; G Buck; C Pollicino; A Kirby; T Sourjina; R Peto; R Collins; R Simes
Journal:  Lancet       Date:  2005-09-27       Impact factor: 79.321

4.  Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies.

Authors:  Emily B Levitan; Yiqing Song; Earl S Ford; Simin Liu
Journal:  Arch Intern Med       Date:  2004-10-25

5.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

Authors:  Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew W Neil; Shona J Livingstone; Margaret J Thomason; Michael I Mackness; Valentine Charlton-Menys; John H Fuller
Journal:  Lancet       Date:  2004 Aug 21-27       Impact factor: 79.321

6.  Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.

Authors:  J Stamler; O Vaccaro; J D Neaton; D Wentworth
Journal:  Diabetes Care       Date:  1993-02       Impact factor: 19.112

Review 7.  Dyslipidemia in Nigeria: prevalence and pattern.

Authors:  O C Oguejiofor; C H Onwukwe; C U Odenigbo
Journal:  Ann Afr Med       Date:  2012 Oct-Dec

Review 8.  [AIP--atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice].

Authors:  M Dobiásová
Journal:  Vnitr Lek       Date:  2006-01

9.  Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.

Authors:  Børge G Nordestgaard; Marianne Benn; Peter Schnohr; Anne Tybjaerg-Hansen
Journal:  JAMA       Date:  2007-07-18       Impact factor: 56.272

10.  Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015.

Authors:  Gregory A Roth; Catherine Johnson; Amanuel Abajobir; Foad Abd-Allah; Semaw Ferede Abera; Gebre Abyu; Muktar Ahmed; Baran Aksut; Tahiya Alam; Khurshid Alam; François Alla; Nelson Alvis-Guzman; Stephen Amrock; Hossein Ansari; Johan Ärnlöv; Hamid Asayesh; Tesfay Mehari Atey; Leticia Avila-Burgos; Ashish Awasthi; Amitava Banerjee; Aleksandra Barac; Till Bärnighausen; Lars Barregard; Neeraj Bedi; Ezra Belay Ketema; Derrick Bennett; Gebremedhin Berhe; Zulfiqar Bhutta; Shimelash Bitew; Jonathan Carapetis; Juan Jesus Carrero; Deborah Carvalho Malta; Carlos Andres Castañeda-Orjuela; Jacqueline Castillo-Rivas; Ferrán Catalá-López; Jee-Young Choi; Hanne Christensen; Massimo Cirillo; Leslie Cooper; Michael Criqui; David Cundiff; Albertino Damasceno; Lalit Dandona; Rakhi Dandona; Kairat Davletov; Samath Dharmaratne; Prabhakaran Dorairaj; Manisha Dubey; Rebecca Ehrenkranz; Maysaa El Sayed Zaki; Emerito Jose A Faraon; Alireza Esteghamati; Talha Farid; Maryam Farvid; Valery Feigin; Eric L Ding; Gerry Fowkes; Tsegaye Gebrehiwot; Richard Gillum; Audra Gold; Philimon Gona; Rajeev Gupta; Tesfa Dejenie Habtewold; Nima Hafezi-Nejad; Tesfaye Hailu; Gessessew Bugssa Hailu; Graeme Hankey; Hamid Yimam Hassen; Kalkidan Hassen Abate; Rasmus Havmoeller; Simon I Hay; Masako Horino; Peter J Hotez; Kathryn Jacobsen; Spencer James; Mehdi Javanbakht; Panniyammakal Jeemon; Denny John; Jost Jonas; Yogeshwar Kalkonde; Chante Karimkhani; Amir Kasaeian; Yousef Khader; Abdur Khan; Young-Ho Khang; Sahil Khera; Abdullah T Khoja; Jagdish Khubchandani; Daniel Kim; Dhaval Kolte; Soewarta Kosen; Kristopher J Krohn; G Anil Kumar; Gene F Kwan; Dharmesh Kumar Lal; Anders Larsson; Shai Linn; Alan Lopez; Paulo A Lotufo; Hassan Magdy Abd El Razek; Reza Malekzadeh; Mohsen Mazidi; Toni Meier; Kidanu Gebremariam Meles; George Mensah; Atte Meretoja; Haftay Mezgebe; Ted Miller; Erkin Mirrakhimov; Shafiu Mohammed; Andrew E Moran; Kamarul Imran Musa; Jagat Narula; Bruce Neal; Frida Ngalesoni; Grant Nguyen; Carla Makhlouf Obermeyer; Mayowa Owolabi; George Patton; João Pedro; Dima Qato; Mostafa Qorbani; Kazem Rahimi; Rajesh Kumar Rai; Salman Rawaf; Antônio Ribeiro; Saeid Safiri; Joshua A Salomon; Itamar Santos; Milena Santric Milicevic; Benn Sartorius; Aletta Schutte; Sadaf Sepanlou; Masood Ali Shaikh; Min-Jeong Shin; Mehdi Shishehbor; Hirbo Shore; Diego Augusto Santos Silva; Eugene Sobngwi; Saverio Stranges; Soumya Swaminathan; Rafael Tabarés-Seisdedos; Niguse Tadele Atnafu; Fisaha Tesfay; J S Thakur; Amanda Thrift; Roman Topor-Madry; Thomas Truelsen; Stefanos Tyrovolas; Kingsley Nnanna Ukwaja; Olalekan Uthman; Tommi Vasankari; Vasiliy Vlassov; Stein Emil Vollset; Tolassa Wakayo; David Watkins; Robert Weintraub; Andrea Werdecker; Ronny Westerman; Charles Shey Wiysonge; Charles Wolfe; Abdulhalik Workicho; Gelin Xu; Yuichiro Yano; Paul Yip; Naohiro Yonemoto; Mustafa Younis; Chuanhua Yu; Theo Vos; Mohsen Naghavi; Christopher Murray
Journal:  J Am Coll Cardiol       Date:  2017-05-17       Impact factor: 24.094

View more
  5 in total

1.  Predictors of Lipid Profile Abnormalities Among Patients with Metabolic Syndrome in Southwest Ethiopia: A Cross-Sectional Study.

Authors:  Kassahun Haile; Admasu Haile; Abebe Timerga
Journal:  Vasc Health Risk Manag       Date:  2021-08-08

2.  Prevalence, patterns and determinants of dyslipidaemia among South African adults with comorbidities.

Authors:  Charity Masilela; Oladele Vincent Adeniyi; Mongi Benjeddou
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.996

3.  Associations of visit-to-visit variabilities and trajectories of serum lipids with the future probability of type 2 diabetes mellitus.

Authors:  Qian Sun; Jingchao Liu; Lei Wu; Yue Sun; Jianrong Jin; Sudan Wang; Jing Wu; Yang Jing; Hui Zhou; Chen Dong
Journal:  Lipids Health Dis       Date:  2021-11-27       Impact factor: 3.876

4.  Prevalence and Risk Factors of Dyslipidemia among Type 2 Diabetes Patients at a Referral Hospital, North Eastern Ethiopia.

Authors:  Worku Misganaw Kebede; Kefyalew Dagne Gizachew; Getaneh Baye Mulu
Journal:  Ethiop J Health Sci       Date:  2021-11

5.  The pattern of dyslipidaemia and factors associated with elevated levels of non-HDL-cholesterol among patients with type 2 diabetes mellitus in the Ho municipality: A cross sectional study.

Authors:  Sylvester Yao Lokpo; Roger Laryea; James Osei-Yeboah; William K B A Owiredu; Richard K D Ephraim; Esther Ngozi Adejumo; Samuel Ametepe; Michael Appiah; Nogo Peter; Patrick Affrim; Precious Kwablah Kwadzokpui; Ohene Kweku Abeka
Journal:  Heliyon       Date:  2022-08-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.